Synthesis, expression and biological activity of the prohormone for gastrin releasing peptide (ProGRP).

Endocrinology 2006 Jan 13;147(1):502-9. Epub 2005 Oct 13.

Department of Surgery, Austin Health, University of Melbourne, Heidelberg, Victoria 3084, Australia.

Gastrin-releasing peptide (GRP) has a widespread distribution and multiple stimulating effects on endocrine and exocrine secretions and metabolism. The prohormone for GRP (ProGRP, 125 amino acids) is processed to the amidated, biologically active end products GRP(1-27) and GRP(18-27). Amidated forms of GRP are putative autocrine or paracrine growth factors in a number of cancers including colorectal cancer. However, the potential role and biological activity of proGRP has not been investigated. Using a newly developed antisera directed to the N terminus of human proGRP, proGRP immunoreactivity was detected in all of the endometrial, prostate, and colon cancer cell lines tested and in nine of 10 resected colorectal carcinomas. However, no amidated forms were detected, suggesting an attenuation of processing in tumors. Recombinant proGRP was expressed as a His-tag fusion protein and purified by metal affinity chromatography and HPLC. ProGRP stimulated proliferation of a colon cancer cell line and activated MAPK, but unlike GRP(18-27)amide had no effect on inositol phosphate production. ProGRP did not compete with iodinated bombesin in binding assays on Balb-3T3 cells transfected with the known GRP receptors, GRP-R or BRS-3. We conclude that proGRP is present in a number of cancer cell lines and in resected colorectal tumors and is biologically active. Our results suggest that antagonists to GRP precursors rather than the amidated end products should be developed as a treatment for colorectal and other cancers that express proGRP-derived peptides.

Download full-text PDF

Source
http://dx.doi.org/10.1210/en.2005-0574DOI Listing
January 2006

Publication Analysis

Top Keywords

cancer cell
12
progrp
9
biologically active
8
amidated forms
8
biological activity
8
colon cancer
8
cell lines
8
resected colorectal
8
grp
5
immunoreactivity detected
4
cells transfected
4
progrp immunoreactivity
4
transfected grp
4
human progrp
4
progrp progrp
4
detected endometrial
4
endometrial prostate
4
balb-3t3 cells
4
conclude progrp
4
cancers including
4

Similar Publications